(Alliance News) - Staff who work on patrol boats in the English Channel have voted for strike action in a dispute over allowances. The Public & Commercial Services union, PCS, said more than 100 of ...

(Alliance News) - Two vessels involved in a North Sea collision that triggered a huge explosion "appear to be relatively stable" and the environmental impact "mercifully small", a transport minister ...

(Alliance News) - Eric Trump, son of the US president, met with Scotland's First Minister John Sweeney Thursday, with talks focused on Donald Trump's golf ventures in the country.

(Alliance News) - Vladimir Putin has said he agrees in principle to a 30-day ceasefire with Ukraine as Downing Street warned that if the war continued sanctions would "cripple" the Russian economy.

(Alliance News) - Thames Water must wait to discover whether the approval of a plan to restructure the struggling utility will be overturned at the Court of Appeal.

(Alliance News) - Irish premier Micheal Martin has called for the EU to adopt a "strategic approach" around US tariffs, as he predicted difficulties for the Irish spirits industry. Martin was reacting ...

(Alliance News) - Ethernity Networks Ltd on Thursday said it expects to win an additional USD290,000 in a contract extension with a US-based aerospace system products provider.

The FTSE 100 index closed up just 1.59 points at 8,542.56. The FTSE 250 dropped 197.94 points, 1.0%, at 19,688.57, and the AIM All-Share fell 1.46 points, 0.2%, at 679.46. The Cboe UK 100 rose 0.1% at ...

(Alliance News) - Oxford BioDynamics PLC on Thursday announced an expanded strategic agreement with UK health insurance provider Bupa. The stock closed 9.7% higher at 0.52 pence per share on Thursday ...

(Alliance News) - LMS Capital PLC on Thursday said it will seek approval from shareholders for a managed realisation of its assets, following a review of its options. LMS Capital shares surged 16% to ...

(Alliance News) - Dar Global PLC on Thursday said it remains on track for its targets as it reported a fall in revenue and profit for 2024. The London-based luxury real estate developer which ...

ImmuPharma said the findings are from a new preclinical study designed by ImmuPharma Biotech's team, and will allow the company "to further expand its intellectual property portfolio, with additional ...